Cargando…
NPM1A in Plasma is a Potential Prognostic Biomarker in Acute Myeloid Leukemia
OBJECTIVE: The aim of the study was to investigate whether nucleophosmin type A mutation (NPM1A) in plasma was associated with the prognosis of patients with acute myeloid leukemia (AML). METHODS: Plasma NPM1A levels were investigated in 80 AML patients, 22 patients with benign hematopathy and 12 he...
Autores principales: | Sun, Chengming, Gao, Yujie, Yang, Liping, Shao, Huiyuan, li, Jie, Gao, Xuejun, Ma, Li, Lin, Mingming, Sui, Jingrui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874735/ https://www.ncbi.nlm.nih.gov/pubmed/33817088 http://dx.doi.org/10.1515/biol-2018-0028 |
Ejemplares similares
-
The Diagnostic Efficacy of Thrombelastography (TEG) in Patients with Preeclampsia and its Association with Blood Coagulation
por: Lidan, He, et al.
Publicado: (2019) -
Evaluation of the Quality of CT Images Acquired with Smart Metal Artifact Reduction Software
por: Zhou, Peng, et al.
Publicado: (2018) -
Risk Factors of Regional Lymph Node Metastasis in Patients with Cervical Cancer
por: Wu, Chunchun, et al.
Publicado: (2019) -
Serum sTREM-1, PCT, CRP, Lac as Biomarkers for Death Risk Within 28 Days in Patients with Severe Sepsis
por: Zhang, Lefeng, et al.
Publicado: (2018) -
IL-17 Gene Rs3748067 C>T Polymorphism and Gastric Cancer Risk: A Meta-analysis
por: Ying, Wang, et al.
Publicado: (2018)